Article Details

Dr. Ferrajoli on the Benefits and Limitations of Frontline Fixed-Duration Therapy in CLL

Retrieved on: 2023-09-15 18:03:21

Tags for this article:

Click the tags to see associated articles and topics

Dr. Ferrajoli on the Benefits and Limitations of Frontline Fixed-Duration Therapy in CLL. View article details on hiswai:

Excerpt

Alessandra Ferrajoli, MD, discusses the benefits and limitations of utilizing fixed-duration therapy with monoclonal antibodies in the frontline ...

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up